Eric Aguiar, Director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 30,000 shares at $56.39 ($1.7M) on 2020-01-09, disclosed to the SEC on 2020-01-10.
Open-market sale of $1.7M BHVN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NVTA | SELL | 2020-07-16 | $680K | — | Filing → |
| BHVN | SELL | 2020-01-24 | $114K | — | Filing → |
| BHVN | SELL | 2019-12-18 | $390K | — | Filing → |